ScholarIQanswers from OpenAlex & ORCID
Ahmad Awada
ResearcherPublications, citations & collaboration network
Ahmad Awada is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ahmad Awada have?
ScholarIQindexed works
Ahmad Awada has 1,001 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ahmad Awada have?
ScholarIQcitation count
Ahmad Awada has 25,585 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ahmad Awada?
ScholarIQh-index
Ahmad Awada has an h-index of 76 in OpenAlex.
What is the i10-index of Ahmad Awada?
ScholarIQi10-index
Ahmad Awada has an i10-index of 341 in OpenAlex.
What is the ORCID of Ahmad Awada?
ScholarIQorcid
The ORCID for Ahmad Awada is on the source record.
What is the OpenAlex record for Ahmad Awada?
ScholarIQopenalex
The OpenAlex for Ahmad Awada is on the source record.
What are the most-cited papers on Ahmad Awada?
ScholarIQmost cited works
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Sylvia Adams, P. Schmid, H. S. Rugo, EP Winer, D. Loirat, Ahmad Awada, D.W. Cescon, Hiromitsu Iwata, M. Campone, Rita Nanda, Rita L. Hui, Giuseppe Curigliano, D. Toppmeyer, Joyce O’Shaughnessy, Sherene Loi, Shani Paluch–Shimon, Antoinette R. Tan, Deborah Card, Jing Zhao, V. Karantza, Javier Cortés
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial
José Trigo, Vivek Subbiah, Benjamin Besse, Víctor Moreno, Rafael López‐López, María Ángeles Sala, Solange Peters, Santiago Ponce, Cristian Fernández, Vicente Alfaro, Javier Gómez, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Maite Martínez, Jean‐Pierre Delord, Ahmad Awada, Rebecca Kristeleit, M.E. Olmedo, Luciano Wannesson, Javier Valdivia, María Jesús Rubio, Antonio Antón, John Sarantopoulos, Sant P. Chawla, Joaquín Mosquera, M. D’Arcangelo, Armando Santoro, Víctor M. Villalobos, Jacob Sands, Luis Paz‐Ares
Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
Jeremy Lewin, Jean‐Charles Soria, Anastasios Stathis, Jean‐Pierre Delord, Solange Peters, Ahmad Awada, Philippe Aftimos, Mohamed Békradda, Keyvan Rezaï, Zhen Zeng, Azher Hussain, Susan Perez, Lillian L. Siu, Christophe Massard
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Michele Maio, Michele Maio, Karl Lewis, Lev Demidov, Mario Mandalà, Igor Bondarenko, Paolo A Ascierto, Christopher Herbert, Andrzej Maćkiewicz, Piotr Rutkowski, Alexander Guminski, Grant R. Goodman, Brian Simmons, Chenglin Ye, Yibing Yan, Dirk Schadendorf, Gabriela Cinat, Luis Fein, Michael P. Brown, Alexander Guminski, Andrew Haydon, Adnan Khattak, Catriona M. McNeil, Phillip Parente, Jeremy Power, Rachel Roberts‐Thomson, Shahneen Sandhu, Craig Underhill, Suresh Varma, Thomas Berger, Ahmad Awada, Nathalie Blockx, Véronique Buyse, Jeroen Mebis, Fábio Franke, Sérgio Jobim Azevedo, Nicolas Lazaretti, Rahima Jamal, Catalin Mihalcioiu, Teresa M. Petrella, Kerry J. Savage, Ralph Wong, Ralph Wong, Nina Dabelić, Stjepko Pleština, Željko Vojnović, Petr Arenberger, Ivo Kocák, Ivana Krajsová, Eugen Kubala, Bohuslav Melichar, Yvetta Vantuchová, Kadri Putnik, Brigitte Dréno, Caroline Dutriaux, Jean‐Jacques Grob, P. Joly, J.‐P. Lacour, Nicolás Meyer, Laurent Mortier, L. Thomas, Michael Fluck, Thilo Gambichler, Jessica C. Hassel, Axel Hauschild, Dirk Schadendorf, Paul Donnellan, John McCaffrey, Derek G. Power, Samuel Ariad, Gil Bar‐Sela, Daniel Hendler, Ilan G. Ron, Jacob Schachter, Paolo Ascierto, Alfredo Berruti, Luca Bianchi, Vanna Chiarion‐Sileni, Francesco Cognetti, Riccardo Danielli, Anna Maria Di Giacomo, Luca Gianni, Aron Goldhirsch, Michele Guida, Michele Maio, Michele Maio, Mario Mandalà, Paolo Marchetti, Paola Queirolo, Armando Santoro, Ellen Kapiteijn, Andrzej Mackiewicz, Piotr Rutkowski, P. Ferreira, Lev Demidov, Georgy Gafton, Yulia Makarova, Zoran Andrić, Nada Babović, Darjana Jovanovic
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
Sara M. Tolaney, Solmaz Sahebjam, Émilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise A. Yardley, Arlene Chan, PierFranco Conte, Véronique Dièras, Nancy U. Lin, Melissa Bear, Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders